Louise Rodino Klapac Sarepta Therapeutics, Inc. (SRPT) insider trading activity

SRPT Quotes by TradingView

Louise Rodino Klapac is Head of R&D, CSO of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 76,355 shares of SRPT, which is worth approximately $1.44 Million. The most recent transaction as insider was on Nov 16, 2021, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.4K
0% 3M change
5.84% 12M change
Total Value Held $1.44 Million

Louise Rodino-Klapac Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2021
BUY
Grant, award, or other acquisition
-
40,000 Added 39.25%
61,898 Common Stock
Mar 03 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 40.36%
22,169 Common Stock
LR

Louise Rodino Klapac

Head of R&D, CSO
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRPT